Katherine D Crothall

US Patent:

7179226, Feb 20, 2007

Filed:

Jun 19, 2002

Appl. No.:

10/176390

Inventors:

Katherine D. Crothall - Haverford PA, US
Peter Laakmann - Haverford PA, US

Assignee:

Animas Corporation - West Chester PA

International Classification:

A61B 5/00

US Classification:

600300, 128920

Abstract:

A diabetes management system and method used to manage the blood glucose level of a diabetes patient. The system includes at least one portable electronic device and a database system. The portable electronic device allows the patient to input different types of data into the processor to calculate insulin and carbohydrate intake recommendations for the patient. A time/date stamp is individually generated and stored for each type of data inputted by the patient. The diabetes management system also includes a database system which stores (i) activity data associated with the physical activity of the patient, (ii) blood glucose data associated with the blood glucose level of the patient, (iii) meal intake data associated with the food intake of the patient, and (iv) insulin intake data associated with the insulin intake of the patient.

US Patent:

20070149861, Jun 28, 2007

Filed:

Feb 16, 2007

Appl. No.:

11/707802

Inventors:

Katherine Crothall - Haverford PA, US
Peter Laakmann - Haverford PA, US

International Classification:

A61B 5/00
A61M 31/00

US Classification:

600300000, 128920000, 604065000

Abstract:

A diabetes management system, an infusion pump, and methods for managing a blood glucose level of a diabetes patient. The infusion pump includes a processor for monitoring an amount of insulin delivered to a patient and an internal database in communication with the processor. The internal database is for storing food information. The diabetes management system includes a blood glucose monitor, a food database, and an infusion pump for delivering insulin to a patient. The food database comprises one or more records of information on various foods. The infusion pump of the diabetes management system includes (i) a processor for monitoring an amount of insulin delivered to the patient and (ii) a second database. The second database is for receiving at least a portion of the information from the food database.

US Patent:

20080312584, Dec 18, 2008

Filed:

Jun 15, 2007

Appl. No.:

11/764023

Inventors:

Barbara A. Montgomery - Malvern PA, US
Krzysztof Z. Brukalo - Chambersburg PA, US
Manfred Ebner - Oberursel, DE
Steven Getz - Malvern PA, US
Carl Brewer - Ephrata PA, US
Ulrich Kraft - Hofheim, DE
Mark DeStefano - Collegeville PA, US
Sieghard Hasenzahl - Riedstadt, DE
Katherine D. Crothall - Gladwyne PA, US
David Hohl - Milpitas CA, US

Assignee:

Animas Corporation - West Chester PA

International Classification:

A61M 31/00

US Classification:

604 67, 600300

Abstract:

A disease management system, methods, and devices are shown and described. In one embodiment, the system includes an infusion pump and a remote controller with the ability to be paired to each other. A method to verify a wireless connection between an infusion pump and a remote controller is shown and described herein. In a further embodiment, a method to verify a wireless connection between an infusion pump and a remote controller is provided. In addition, a method of operating a diabetes management system is provided in which the system includes an infusion pump and at least a remote controller.

US Patent:

60497270, Apr 11, 2000

Filed:

Apr 3, 1998

Appl. No.:

9/054806

Inventors:

Katherine D. Crothall - Haverford PA

Assignee:

Animas Corporation - Malvern PA

International Classification:

A61K 922

US Classification:

600310

Abstract:

An in vivo implantable sensor obtains spectra of body fluid constituents and processes the spectra to determine the concentration of a constituent of the body fluid. The sensor includes an optical source and detector. The source emits light at a `plurality of different, discrete wavelengths, including at least one wavelength in the infrared region. The light interacts with the body fluid and is received at the detector. The light at the plurality of different wavelengths has a substantially collinear optical path through the fluid with respect to each other. When measuring fluid constituents in a blood vessel, such as blood glucose, the light at the plurality of different wavelengths is emitted in a substantially single period of time. The spectra is corrected for artifacts introduced from extraneous tissue in the optical path between the source and the detector. The sensor is fully implanted and is set in place to allow plural measurements to be taken at different time periods from a single in vivo position.

US Patent:

55965938, Jan 21, 1997

Filed:

Feb 9, 1996

Appl. No.:

8/598899

Inventors:

Katherine D. Crothall - Gladwyne PA
Edward S. Schieferstein - Everett WA
Steven E. Wojcik - Lynnwood WA

Assignee:

Luxar Corporation - Bothell WA

International Classification:

H01S 3097

US Classification:

372 87

Abstract:

A gas laser having a housing including a discharge region that contains a lasing gas medium, a pair of DC electrodes having primary surfaces facing toward the discharge region, the primary surfaces being arranged in substantially parallel planes, and a pair of RF electrodes having secondary surfaces facing toward the discharge region, the secondary surfaces being in substantially parallel planes with the secondary surfaces being arranged substantially orthogonal to the primary surfaces. The gas laser also has an RF power source connected between said pair of RF electrodes and selectively generating an RF discharge in the discharge region, and a DC power source connected between said pair of DC electrodes and selectively generating a DC discharge in the discharge region.

US Patent:

61225363, Sep 19, 2000

Filed:

Jun 23, 1998

Appl. No.:

8/981860

Inventors:

Xiaoguong Sun - King of Prussia PA
Jeffrey I. Joseph - Penn Valley PA
Katherine D. Crothall - Gladwyne PA

Assignee:

Animas Corporation - Malvern PA

International Classification:

A61B 500
A61M 5142

US Classification:

600341

Abstract:

This invention is an implantable sensor and system capable of measuring, controlling, monitoring and reporting blood constituent levels. The implantable sensor for sensing in vivo the level of at least one blood constituent in mammalian vascular tissue having at least one source of radiation from infrared through visible light, arranged to direct the radiation at the tissue where it is affected by interaction with the tissue, and at least one detector. The invention also encompasses a device for measuring and controlling the level of a blood constituent, such as glucose or oxygen, and includes an implantable infrared source module for generating an output signal representative of the sensed infrared radiation. The system includes a processor module responsive to the output signal which performs spectral analysis of the output signal and generates a control signal. The system further includes other devices for dispensing doses of medications or controlling organ function in response to the control signal.